Synthesis of Novel Peptide Inhibitors of Thrombin-induced Platelet Activation
dc.contributor.author | Burke, Fernanda Ferraccioli Marques | en_US |
dc.contributor.author | Warnock, Mark | en_US |
dc.contributor.author | Schmaier, Alvin H. | en_US |
dc.contributor.author | Mosberg, Henry I. | en_US |
dc.date.accessioned | 2010-04-01T15:17:24Z | |
dc.date.available | 2010-04-01T15:17:24Z | |
dc.date.issued | 2006-11 | en_US |
dc.identifier.citation | Burke, Fernanda M.; Warnock, Mark; Schmaier, Alvin H.; Mosberg, Henry I. (2006). "Synthesis of Novel Peptide Inhibitors of Thrombin-induced Platelet Activation." Chemical Biology & Drug Design 68(5): 235-238. <http://hdl.handle.net/2027.42/65762> | en_US |
dc.identifier.issn | 1747-0277 | en_US |
dc.identifier.issn | 1747-0285 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/65762 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17177882&dopt=citation | en_US |
dc.format.extent | 64620 bytes | |
dc.format.extent | 3110 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 2006 The Authors Journal compilation 2006 Blackwell Munksgaard | en_US |
dc.subject.other | Bradykinin | en_US |
dc.subject.other | Protease-activated Receptor | en_US |
dc.subject.other | Platelet Aggregation | en_US |
dc.subject.other | Thrombin | en_US |
dc.subject.other | Thrombin Receptor | en_US |
dc.title | Synthesis of Novel Peptide Inhibitors of Thrombin-induced Platelet Activation | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, 428 Church Street, Ann Arbor, MI 48109-1065, USA | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109-0368, USA | en_US |
dc.contributor.affiliationother | Division of Hematology/Oncology, Department of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA | en_US |
dc.identifier.pmid | 17177882 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/65762/1/j.1747-0285.2006.00442.x.pdf | |
dc.identifier.doi | 10.1111/j.1747-0285.2006.00442.x | en_US |
dc.identifier.source | Chemical Biology & Drug Design | en_US |
dc.identifier.citedreference | Paoli G., Merlini P.A., Ardissino D. ( 2005 ) Direct thrombin inhibitors for the treatment of acute coronary syndromes and during percutaneous coronary interventions. Curr Pharm Des ; 11 : 3919 – 3929. | en_US |
dc.identifier.citedreference | Chung A.W., Jurasz P., Hollenberg M.D., Radomski M.W. ( 2002 ) Mechanisms of action of proteinase-activated receptor agonists on human platelets. Br J Pharmacol ; 135 : 1123 – 1132. | en_US |
dc.identifier.citedreference | Coughlin S.R. ( 2000 ) Thrombin signalling and protease-activated receptors. Nature ; 407 : 258 – 264. | en_US |
dc.identifier.citedreference | Callahan K.P., Malinin A.I., Gurbel P.A., Alexander J.H., Granger C.B., Serebruany V.L. ( 2001 ) Platelet function and fibrinolytic agents: two sides of a coin ? Cardiology ; 95 : 55 – 60. | en_US |
dc.identifier.citedreference | Colman R.W., White J.V., Scovell S., Stadnicki A., Sartor R.B. ( 1999 ) Kininogens are antithrombotic proteins in vivo. Arterioscler Thromb Vasc Biol ; 19 : 2245 – 2250. | en_US |
dc.identifier.citedreference | Murphey L.J., Hachey D.L., Oates J.A., Morrow J.D., Brown N.J. ( 2000 ) Metabolism of bradykinin in vivo in humans: identification of BK1–5 as a stable plasma peptide metabolite. J Pharmacol Exp Ther ; 294 : 263 – 269. | en_US |
dc.identifier.citedreference | Hasan A.A., Warnock M., Srikanth S., Schmaier A.H. ( 2001 ) Developing peptide inhibitors to thrombin activation of platelets from bradykinin analogs. Thromb Res ; 104 : 451 – 465. | en_US |
dc.identifier.citedreference | Hasan A.A., Warnock M., Nieman M., Srikanth S., Mahdi F., Krishnan R. et al. ( 2003 ) Mechanisms of Arg-Pro-Pro-Gly-Phe inhibition of thrombin. Am J Physiol Heart Circ Physiol ; 285 : H183 – 193. | en_US |
dc.identifier.citedreference | Hasan A.A., Amenta S., Schmaier A.H. ( 1996 ) Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, are selective inhibitors of alpha-thrombin-induced platelet activation. Circulation ; 94 : 517 – 528. | en_US |
dc.identifier.citedreference | Nieman M.T., Warnock M., Hasan A.A., Mahdi F., Lucchesi B.R., Brown N.J. et al. ( 2004 ) The preparation and characterization of novel peptide antagonists to thrombin and factor VIIa and activation of protease-activated receptor 1. J Pharmacol Exp Ther ; 311 : 492 – 501. | en_US |
dc.identifier.citedreference | Barany G., Merrifield R.B. ( 1980 ) The Peptides. Analysis, Synthesis, Biology. New York : Academic Press. | en_US |
dc.identifier.citedreference | Stewart J.M., Young J.D. ( 1984 ) Solid-Phase Peptide Synthesis, 2nd edn. Rockford, Illinois : Pierce Chemical Company. | en_US |
dc.identifier.citedreference | Fields G.B., Noble R.L. ( 1990 ) Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res ; 35 : 161 – 214. | en_US |
dc.identifier.citedreference | Fields C.G., Lloyd D.H., Macdonald R.L., Otteson K.M., Noble R.L. ( 1991 ) HBTU activation for automated Fmoc solid-phase peptide synthesis. Pept Res ; 4 : 95 – 101. | en_US |
dc.identifier.citedreference | Lembeck F., Griesbacher T., Eckhardt M., Henke S., Breipohl G., Knolle J. ( 1991 ) New, long-acting, potent bradykinin antagonists. Br J Pharmacol ; 102 : 297 – 304. | en_US |
dc.identifier.citedreference | Stewart J.M. ( 2004 ) Bradykinin antagonists: discovery and development. Peptides ; 25 : 527 – 532. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.